Literature DB >> 10719789

Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications.

F M Wurst1, C Kempter, J Metzger, S Seidl, A Alt.   

Abstract

A marker with a specific time spectrum of detection and both high sensitivity and specificity is required to diminish the clinically as well as forensically important gap on the time axis between short- and long-term markers of alcohol consumption like ethanol and CDT, GGT or MCV, respectively. Ethyl glucuronide (EtG) is a non-volatile, water-soluble, stable upon storage, direct metabolite of ethanol with a molecular weight of 222 g/mol that can be detected in body fluids for an extended time period after the complete elimination of alcohol from the body. We investigated 107 urine and 78 serum samples of a total of 107 inpatients in 4 groups: (1) 33 inpatients in acute alcohol withdrawal and long term treatment; (2/3) 29 and 15 addicted forensic psychiatric inpatients (#64 StGB, penal code); (4) 30 recently detoxified inpatients of a station for long term treatment by LC/MS-MS with the internal standard d5-EtG and additionally in the fourth group of patients also by gas chromatography/mass spectrometry (GC/MS). In 2 out of 33 inpatients of the first group, EtG could be determined 3 days after hospitalization; in an other subject, a relapse could be detected. In 2 out of 29 and in 1 out of 15 forensic inpatients of group 2 and 3, respectively--where neither clinical impression nor routine laboratory findings gave an indication for relapse--concentrations of EtG ranged between 0.1 and 18 mg/l in urine. For the serum samples of the 30 inpatients of group 4, we could demonstrate a total agreement for the results of the GC/MS and the LC/MS-MS method as to whether a sample was found to be positive or negative for EtG. We suggest that these results strengthen our earlier findings that ethyl glucuronide is a marker of alcohol consumption in general that can be detected for an extended time period after the complete elimination of alcohol from the body and a marker for relapse control with a specific time frame of detection intermediate between short- and long-term markers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719789     DOI: 10.1016/s0741-8329(99)00076-2

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  16 in total

Review 1.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

2.  Evaluation of biomarkers assessing regular alcohol consumption in an occupational setting.

Authors:  Sonja Kilo; Birgit Hofmann; Elisabeth Eckert; Thomas Göen; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2016-07-09       Impact factor: 3.015

3.  Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients.

Authors:  Michael G McDonell; Jordan Skalisky; Emily Leickly; Sterling McPherson; Samuel Battalio; Jenny R Nepom; Debra Srebnik; John Roll; Richard K Ries
Journal:  Drug Alcohol Depend       Date:  2015-10-09       Impact factor: 4.492

4.  Influence of Gilbert's syndrome on the formation of ethyl glucuronide.

Authors:  Laura M Huppertz; Leonie Gunsilius; Christelle Lardi; Wolfgang Weinmann; Annette Thierauf-Emberger
Journal:  Int J Legal Med       Date:  2015-02-14       Impact factor: 2.686

5.  A high-performance liquid chromatographic-tandem mass spectrometric method for the determination of ethyl glucuronide and ethyl sulfate in urine validated according to forensic guidelines.

Authors:  M E Albermann; F Musshoff; B Madea
Journal:  J Chromatogr Sci       Date:  2012-01       Impact factor: 1.618

6.  Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design, methodology, and baseline data.

Authors:  Ekaterina Burduli; Jordan Skalisky; Katherine Hirchak; Michael F Orr; Albert Foote; Alexandria Granbois; Richard Ries; John M Roll; Dedra Buchwald; Michael G McDonell; Sterling M McPherson
Journal:  Clin Trials       Date:  2018-08-29       Impact factor: 2.486

7.  Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users.

Authors:  Jennifer Jain; Jennifer L Evans; Alya Briceño; Kimberly Page; Judith A Hahn
Journal:  Alcohol Alcohol       Date:  2014-06-17       Impact factor: 2.826

8.  Liver proteome analysis in a rodent model of alcoholic steatosis.

Authors:  Billy W Newton; William K Russell; David H Russell; Shashi K Ramaiah; Arul Jayaraman
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

9.  Liver proteomics in progressive alcoholic steatosis.

Authors:  Harshica Fernando; John E Wiktorowicz; Kizhake V Soman; Bhupendra S Kaphalia; M Firoze Khan; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-29       Impact factor: 4.219

10.  Confirmatory analysis of ethylglucuronide in urine by liquid-chromatography/electrospray ionization/tandem mass spectrometry according to forensic guidelines.

Authors:  Wolfgang Weinmann; Patrick Schaefer; Annette Thierauf; André Schreiber; Friedrich Martin Wurst
Journal:  J Am Soc Mass Spectrom       Date:  2004-02       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.